Closed cell therapy market to grow from $1.8B in 2024 to $5.3B by 2029, primarily due to CAR-T therapies and regenerative medicine demand.

The automated and closed cell therapy market is expected to grow from $1.8 billion in 2024 to $5.3 billion by 2029, driven by innovations in CAR-T therapies, rising demand for regenerative medicine, and increasing startups. Key growth factors include point-of-care manufacturing and advancements in robotics and AI. The global cell therapy market could reach $61.84 billion by 2032, with North America leading in adoption and research investment.

October 11, 2024
3 Articles